Efficacy and safety of metronomic cyclophosphamide combined with abiraterone and dexamethasone in heavily pretreated metastatic castration-resistant prostate cancer: A retrospective, real-world study.

Authors :: Zhang L
Zhou L
Shi Y
An X
Source :: Asian journal of surgery [Asian J Surg] 2024 Aug; Vol. 47 (8), pp. 3577-3578. Date of Electronic Publication: 2024 Apr 21.
Publication Year :: 2024
Abstract: Competing Interests: Declaration of competing interest The authors have no conflicts of interest to declare in this work.

Subjects :: Humans
Male
Retrospective Studies
Aged
Treatment Outcome
Administration, Metronomic
Androstenes administration & dosage
Middle Aged
Neoplasm Metastasis
Aged, 80 and over
Prostatic Neoplasms, Castration-Resistant drug therapy
Prostatic Neoplasms, Castration-Resistant pathology
Cyclophosphamide administration & dosage
Cyclophosphamide adverse effects
Dexamethasone administration & dosage
Dexamethasone adverse effects
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Antineoplastic Combined Chemotherapy Protocols administration & dosage
Antineoplastic Combined Chemotherapy Protocols adverse effects

Full Text Access

Tools